Canon gets FDA nod for AI-powered CT reconstruction

2019 02 05 17 15 3805 Canon Rsna 2018 400

Canon Medical Systems USA has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its artificial intelligence (AI)-based Advanced Intelligent Clear-IQ Engine (AiCE) image reconstruction technology.

First introduced at RSNA 2018, AiCE employs a deep convolutional neural network to suppress noise and enhance signal, according to the firm. It can reconstruct CT images with better spatial resolution than the company's adaptive iterative dose reduction (AIDR) 3D iterative reconstruction protocol and at a rate three to five times faster than traditional model-based iterative reconstruction (MBIR) methods, Canon said.

Page 1 of 659
Next Page